10 days

Health Data Management

Greg Slabodkin

November 29

You're clear! The Food and Drug Administration has given its clearance to the first continuous glucose monitoring system that can be used to make diabetes treatment decisions in adult patients without calibration using a blood sample from a traditional fingerstick test. The device can be worn for as long as 10 days following a 12-hour start-up period.

One State Street Plaza
27th Floor
New York, NY 10004

Follow Us For Updates

All audience and traffic data based on company reports and estimates as of Q1 2016.© 2017 SourceMedia LLC. All rights reserved. SourceMedia is an Observer Capital company. Use, duplication, or sale of this service, or data contained herein, is strictly prohibited.